These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
977 related articles for article (PubMed ID: 22696357)
21. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial. Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR; BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304 [TBL] [Abstract][Full Text] [Related]
22. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Tanis E; Nordlinger B; Mauer M; Sorbye H; van Coevorden F; Gruenberger T; Schlag PM; Punt CJ; Ledermann J; Ruers TJ Eur J Cancer; 2014 Mar; 50(5):912-9. PubMed ID: 24411080 [TBL] [Abstract][Full Text] [Related]
23. Comparison between fluoropyrimidine-hepatic arterial infusion and systemic chemotherapy for unresectable liver metastases: A protocol for systematic review and meta-analysis based on 16 observational studies. Zhao J; Zheng Y; Liu T; Chang J; Shan H; Cong K Medicine (Baltimore); 2021 Oct; 100(41):e27483. PubMed ID: 34731127 [TBL] [Abstract][Full Text] [Related]
25. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Nelson R; Freels S Cochrane Database Syst Rev; 2004; (2):CD003770. PubMed ID: 15106219 [TBL] [Abstract][Full Text] [Related]
26. WITHDRAWN: Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Al-Asfoor A; Fedorowicz Z Cochrane Database Syst Rev; 2007 Oct; (4):CD006039. PubMed ID: 17943879 [TBL] [Abstract][Full Text] [Related]
28. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes. Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360 [TBL] [Abstract][Full Text] [Related]
29. Hepatic resection vs minimally invasive radiofrequency ablation for the treatment of colorectal liver metastases: a Markov analysis. Khajanchee YS; Hammill CW; Cassera MA; Wolf RF; Hansen PD Arch Surg; 2011 Dec; 146(12):1416-23. PubMed ID: 22288086 [TBL] [Abstract][Full Text] [Related]
30. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Stang A; Fischbach R; Teichmann W; Bokemeyer C; Braumann D Eur J Cancer; 2009 Jul; 45(10):1748-56. PubMed ID: 19356924 [TBL] [Abstract][Full Text] [Related]
31. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230 [TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation of liver metastases from colorectal carcinoma. Feliberti EC; Wagman LD Cancer Control; 2006 Jan; 13(1):48-51. PubMed ID: 16508626 [TBL] [Abstract][Full Text] [Related]
35. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848 [TBL] [Abstract][Full Text] [Related]
36. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. van Amerongen MJ; Jenniskens SFM; van den Boezem PB; Fütterer JJ; de Wilt JHW HPB (Oxford); 2017 Sep; 19(9):749-756. PubMed ID: 28687147 [TBL] [Abstract][Full Text] [Related]
37. Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer. Lin J; Sun H; Zhang W; Hong Z; Lu Z; Pan Z; Hou Z; Peng J Cancer Med; 2022 Nov; 11(22):4225-4235. PubMed ID: 35466587 [TBL] [Abstract][Full Text] [Related]
38. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy. Martin RC; Scoggins CR; McMasters KM J Surg Oncol; 2006 Apr; 93(5):387-93. PubMed ID: 16550574 [TBL] [Abstract][Full Text] [Related]
39. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Tiong L; Maddern GJ Br J Surg; 2011 Sep; 98(9):1210-24. PubMed ID: 21766289 [TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. Weng M; Zhang Y; Zhou D; Yang Y; Tang Z; Zhao M; Quan Z; Gong W PLoS One; 2012; 7(9):e45493. PubMed ID: 23029051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]